Skip to content
http://lifestyle.lmcordoba.com.ar/
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
OnKure Therapeutics, Inc.
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
August 31, 2026
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
August 4, 2026
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
July 2, 2026
OnKure Therapeutics Reports First Quarter 2026 Financial Results
May 23, 2026
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
March 27, 2026
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
March 12, 2026